Advanced Disease Models for tomorrow's therapies


2 November 2017. The development of new therapeutic options in regenerative medicine requires relevant preclinical tests. Innovative in vitro disease model systems such as 3D-cell cultures, 3D bioprinting and organ-on-a-chip model systems have the potential to complement conventional testing methods and speed up the development of new therapy options, particularly in the fields of cell and gene therapy. Currently, the first advanced disease models are being used and they already help to reduce animal testing. At this year's RegMed Forum, on 6 December in Berlin, international experts from industry and academia will discuss the current use and future potential of these model systems.

The Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and Berlin Partner für Wirtschaft und Technologie GmbH are joint organisers of the RegMed Forum 2017 - Advanced Disease Models on 6 December in Berlin. At the Auditorium Friedrichstraße - Quartier 110, experts from academia and industry will discuss how the combination of technology and disease modeling can produce physiologically relevant results and, ultimately, deliver clinical impact.

"The so-called organ-on-a-chip models have the potential to revolutionize drug development," explains Dr. Christoph Feest, administrative director of the BCRT and co-organizer of the RegMed Forum. These chips comprise human tissue or the most basic building blocks of organs that have been integrated into artificial, microfluidic systems. The technology is maturing, says Christoph Feest, and has in recent years evolved from a conceptual idea to a putative alternative for certain animal models: “This welcome progress manifests in the expanding use of such model systems for pre-clinical research across diverse fields. We are delighted to bring together leading researchers, clinical experts and a range of cutting-edge technology providers at the RedMed Forum 2017, offering attendees a platform for stimulating exchange.”

Attendees of the conference can expect a comprehensive program covering the latest trends in disease modeling, presented by eminent speakers from Europe, the United States and Asia. Numerous national and international companies will be showcasing their products, services and technologies at the industrial exhibition. Admission is free. Registration is open until 4 November at https://www.b2match.eu/regmedforum2017.

Website RegMedForum 2017

Website Berlin Partner








<- Back to: News & Events